Neumora Therapeutics (NMRA) Selling, General & Administrative (2022 - 2026)
Neumora Therapeutics (NMRA) recorded Selling, General & Administrative of $12.91 million in Q2 2026, down 15.7% from $15.32 million a year earlier and down 9.5% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Selling, General & Administrative (2022 - 2026) Analysis & Trends
On a TTM basis, Neumora Therapeutics' Selling, General & Administrative came in at $53.16 million as of Jun 30, 2026, down 20.8% year-over-year; for FY2025, it was $60.09 million, down 3.9% from FY2024.
- Annual Selling, General & Administrative has a three-year compound annual growth rate of 24.5% (FY2022 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $62.54 million in FY2024 (+37.5%), $45.48 million in FY2023 (+46.1%) and $31.12 million in FY2022.
- Quarterly Selling, General & Administrative has ranged from $7.2 million in Q4 2022 to $18.79 million in Q1 2025 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has declined for four consecutive quarters, with growth averaging 0.7% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 89.5% in Q3 2023, against a decline of 24.1% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.27 million (Q1 2026), $13.81 million (Q4 2025) and $12.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Neumora Therapeutics | 112.74 Mn | 112.74 Mn | - | 12.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.91 Mn |
| Mar 31, 2026 | 14.27 Mn |
| Dec 31, 2025 | 13.81 Mn |
| Sep 30, 2025 | 12.18 Mn |
| Jun 30, 2025 | 15.32 Mn |
| Mar 31, 2025 | 18.79 Mn |
| Dec 31, 2024 | 17.01 Mn |
| Sep 30, 2024 | 16.02 Mn |
| Jun 30, 2024 | 15.19 Mn |
| Mar 31, 2024 | 14.32 Mn |
| Dec 31, 2023 | 11.24 Mn |
| Sep 30, 2023 | 15.26 Mn |
| Jun 30, 2023 | 9.29 Mn |
| Mar 31, 2023 | 9.68 Mn |
| Dec 31, 2022 | 7.20 Mn |
| Sep 30, 2022 | 8.05 Mn |
API Access
Neumora Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();